Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
Nat Med
; 23(8): 917-928, 2017 Aug 04.
Article
em En
| MEDLINE
| ID: mdl-28777791
ABSTRACT
The global adoption of artemisinin-based combination therapies (ACTs) in the early 2000s heralded a new era in effectively treating drug-resistant Plasmodium falciparum malaria. However, several Southeast Asian countries have now reported the emergence of parasites that have decreased susceptibility to artemisinin (ART) derivatives and ACT partner drugs, resulting in increasing rates of treatment failures. Here we review recent advances in understanding how antimalarials act and how resistance develops, and discuss new strategies for effectively combatting resistance, optimizing treatment and advancing the global campaign to eliminate malaria.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Plasmodium falciparum
/
Resistência Microbiana a Medicamentos
/
Malária Falciparum
/
Antimaláricos
Limite:
Humans
País como assunto:
Asia
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article